Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
MRNA
Moderna
$27.16
Chart
$24.38 (+11.40%)
$31.48 (-13.72%)
$31.48 (-13.72%)
$118.32 (-77.05%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
MRNA
Moderna
Current Price
$27.16
Login to view Moderna (MRNA) recommendation from the last 90 days from financial news and social media.
Chart
$24.38 (+11.40%)
$31.48 (-13.72%)
$31.48 (-13.72%)
$118.32 (-77.05%)
MRNA Latest Analysis
Modernas Options: A Look at What the Big Money is Thinking. Deep-pocketed investors have adopted a bearish approach towards Moderna (NASDAQ:) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in MRNA usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga
Wed Jun 18, 2025
Moderna falls on doubts over new CDC panels backing of RSV vaccine.
Fri Jun 13, 2025
Moderna under pressure despite RSV vaccine approval into wider age group.
Fri Jun 13, 2025
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects.
Fri Jun 13, 2025
FDA expands Modernas RSV vaccine approval to at-risk adults.
Fri Jun 13, 2025
Moderna Receives United States FDA Approval for RSV Vaccine mRESVIA in Adults Aged 1859 at Increased Risk for RSV Disease.
Thu Jun 12, 2025
US FDA approves expanded use of Modernas RSV vaccine for at-risk adults.
Thu Jun 12, 2025
Moderna explores outside financing for vaccine trials shares dip.
Thu Jun 12, 2025
Moderna Inc. (MRNA) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript.
Wed Jun 11, 2025
Why Moderna Stock Is Crumbling. Moderna’.s stock (NASDAQ: MRNA) has plummeted over 80% in the past year largely due to challenges in its vaccine sales. Last year the company announced lower sales projections in Europe following the European Union’.s renegotiated vaccine supply contract with Pfizer a
Wed Jun 11, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MRNA Stock trends
MRNA Stock performance
MRNA Stock analysis
MRNA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
